To sum up, our data suggest that MYC, EGFR, and CCND1 may be key genes by which CAFs act in ovarian cancer chemoresistance, and the p53 pathway, cell cycle pathway, PI3K-Akt pathway, and MAPK pathway may be the key pathways (Fig. 9). The gene discussed is MYC; the disease is ovarian cancer.